Print Friendly, PDF & Email

NCT/Study#

NCT03110107 /

CA022-001

Phase 1/2a First-In-Human Study Of BMS-986218 Monoclonal Antibody Alone And In Combination With Nivolumab In Advanced Solid Tumors

DISEASE GROUP:

Phase 1 Clinical Trials

current phase:

Phase I/II

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587